5AM Ventures II LP (CIK 1386509) reported 19 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-24). Recent activity: Sell SKYE (27,612 shares), Sell SKYE (1,088 shares), Sell SKYE (114,851 shares), Sell SKYE (4,528 shares), Sell SKYE (32,607 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 27,612 | $45,560 |
| 2026-09-24 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 1,088 | $1,795 |
| 2026-09-24 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 114,851 | $184,910 |
| 2026-09-24 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 4,528 | $7,290 |
| 2026-09-18 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 32,607 | $62,279 |
| 2026-09-18 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 1,285 | $2,454 |
| 2026-08-20 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 45,090 | $17,134 |
| 2026-08-20 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 1,830 | $695 |
| 2026-08-20 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 253,080 | $96,170 |
| 2026-08-20 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 10,255 | $3,589 |
| 2026-08-20 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 409 | $143 |
| 2026-08-20 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 57,476 | $20,117 |
| 2026-08-20 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 1,159 | $371 |
| 2026-08-20 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 46 | $15 |
| 2026-08-20 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 6,495 | $2,078 |
| 2025-08-22 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 58,642 | $209,352 |
| 2025-08-22 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 2,314 | $8,261 |
| 2025-08-22 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 163,979 | $560,808 |
| 2025-08-22 | Skye Bioscience, Inc. (SKYE) | 10% Owner | Sell | 6,470 | $22,127 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24